Saturday, November 7, 2020
- 9:00AM-11:00AM
-
Abstract Number: 0646
“An Apple Pie a Day Does Not Keep the Doctor Away”. Fictional Depictions of Gout in Contemporary Film and Television
Metabolic & Crystal Arthropathies Poster- 9:00AM-11:00AM
-
Abstract Number: 0814
“I Want to Switch Back”: Real-world Experience of Switching Intravenous Abatacept and Tocilizumab to Subcutaneous Injection During the COVID-19 Pandemic
RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World- 9:00AM-11:00AM
-
Abstract Number: 0737
“It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome
Pediatric Rheumatology – Clinical Poster II: JIA- 9:00AM-11:00AM
-
Abstract Number: 0630
“No Benefit from a Strict Immobilization in Vertebral Osteomyelitis” Vertebral Immobilization and Neurological Complication in Acute Pyogenic Vertebral Osteomyelitis: SPONDIMMO, a Prospective Cohort of 250 Patients
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 0786
A Combination of Dimensionality Reduction Techniques Reveals Novel HLA-DR+ ‘Candidate’ Antigen-Presenting Cell Subsets (cAPC) in Patients with Rheumatoid Arthritis (RA)
RA – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 0725
A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients
Pediatric Rheumatology – Clinical Poster II: JIA- 9:00AM-11:00AM
-
Abstract Number: 0874
A Multi-Center, Randomized, Double-blind, Placebo-controlled Dose-ranging Study Evaluating Efficacy and Safety of SHR-1314 in Subjects with Moderate-to-Severe Plaque Psoriasis
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 0677
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study
Metabolic & Crystal Arthropathies Poster- 9:00AM-11:00AM
-
Abstract Number: 0649
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients with Uncontrolled Gout Who Have Undergone Kidney Transplantation: Early Data Report
Metabolic & Crystal Arthropathies Poster- 9:00AM-11:00AM
-
Abstract Number: 0581
A Proposed Economic Framework to Model the Consequences of Psoriatic Arthritis Disease Domains
Health Services Research Poster- 9:00AM-11:00AM
-
Abstract Number: 0529
A Prospective Study on the Incidence of a First Thrombo-embolic Event in Patients with Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies
Antiphospholipid Syndrome Poster- 9:00AM-11:00AM
-
Abstract Number: 0798
A Randomized, Double-blind Phase 3 Study Comparing the Efficacy, Safety and Immunogenicity of PF-06410293 (Abrilada™), an Adalimumab (ADL) Biosimilar, and Reference ADL (Humira®) in Patients with Moderate to Severe Active RA: Results from Weeks 52-92
RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World